Primary information |
---|
ID | 13918 |
Uniprot ID | P01042 |
Description | Myomodulin neuropeptides 1 [Cleaved into- Myomodulin-A (MM-A) (Neuron B16 peptide) (PMSMLRL-amide); Myomodulin-B (MM-B) (MMb) (GSYRMMRL-amide); Myomodulin-D (MM-D) (MMd) (GLSMLRL-amide); Myomodulin-F (MM-F) (MMf) (SLNMLRL-amide); Myomodulin-G (MM-G) (MMg) (TLSMLRL-amide); Myomodulin-H (MM-H) (MMh) ( |
Organism | Homo sapiens |
Txonomy | Aplysia ; Aplysiidae ; Aplysioidea ; Aplysiida ; Tectipleura ; Euthyneura ; Heterobranchia (subclass); Gastropoda ; Mollusca ; Lophotrochozoa ; Spiralia ; Protostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
Subcellular Location | secreted |
Developmental Stage | NA |
Similarity | Bradykinin family |
Tissue Specificity | Expressed in all ganglia of the CNS; but only in a subset of neurons including L10 in the abdominal ganglion and B16 in the buccal ganglion. |
Post Translational Modification | NA |
Function | Influence in smooth muscle contraction;induction of hypotension;natriuresis and diuresis;decrease in blood glucose level;it is a mediator of inflammation and causes ; increase in vascular permeability;stimulation of nociceptors ; release of other mediators of inflammation ; it has a cardioprotective effect |
Length | 370 |
Molecular Weight | 42 |
Name | T-kinin |
Sequence | ISLMKRPPGFSPFR |
Sequence map | NA |
PDB ID | NA |
Drugpedia | NA |
Receptor | P46663; P30411; P46663; P30411 |
Domain | NA |
Pharmaceutical Use | NA
|